The Federal Trade Commission said three top pharmacy suppliers made profits of 7,700 percent on a lifesaving hypertension ...

FTC stated that the 'Big 3' PBM organisations collectively generated over £5.94 billion ($7.3 billion) in revenue from 2017 to 2022.

The lawsuit claims that three major healthcare companies were pushing up the price of insulin by 1,200 percent.

UnitedHealth, the biggest insurance company in America, is receiving backlash after an FTC report revealed that it was ...

According to the Federal Trade Commission, UnitedHealth Group has been charging patients markups on lifesaving drugs. Between ...

(Bloomberg) -- Units of CVS Health Corp., Cigna Group and UnitedHealth Group Inc. charged significantly ... organ transplants and other conditions and procedures, the FTC said. The report demonstrates ...

The city of Greensboro has joined a national litigation campaign suing the nation's three largest pharmacy benefit managers and three largest insulin manufacturers with the goal of lowering insulin pr ...

The Federal Trade Commission on Tuesday released an interim report saying that powerful drug middlemen marked up drugs for ...

As Lina Khan, chair of the Federal Trade Commission, ends her tenure this week the FTC posted a second report in six months ...

On the post-earnings call with analysts, Chief Executive Andrew Witty addressed the recent public backlash over high drug costs and transparency of coverage, particularly following killing of Brian ...

Major updates include increasing vigilance related to antitrust and the DOJ’s blocking of UnitedHealth’s merger with Amedisys ...